476 related articles for article (PubMed ID: 16054733)
1. Cell mediated and antibody immune response to inactivated hepatitis A vaccine.
Schmidtke P; Habermehl P; Knuf M; Meyer CU; Sänger R; Zepp F
Vaccine; 2005 Oct; 23(44):5127-32. PubMed ID: 16054733
[TBL] [Abstract][Full Text] [Related]
2. Rapid antibody response after vaccination with a virosomal hepatitis a vaccine.
Ambrosch F; Finkel B; Herzog C; Koren A; Kollaritsch H
Infection; 2004 Jun; 32(3):149-52. PubMed ID: 15188074
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
Dagan R; Greenberg D; Weber F
Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
[TBL] [Abstract][Full Text] [Related]
5. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
[TBL] [Abstract][Full Text] [Related]
6. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.
Van Herck K; Jacquet JM; Van Damme P
J Med Virol; 2011 Nov; 83(11):1885-91. PubMed ID: 21915861
[TBL] [Abstract][Full Text] [Related]
7. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.
Dagan R; Amir J; Livni G; Greenberg D; Abu-Abed J; Guy L; Ashkenazi S; Foresner G; Tewald F; Schätzl HM; Hoffmann D; Ibanez R; Herzog C
Pediatr Infect Dis J; 2007 Sep; 26(9):787-93. PubMed ID: 17721372
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
[TBL] [Abstract][Full Text] [Related]
9. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary course.
Van Herck K; Van Damme P; Lievens M; Stoffel M
J Med Virol; 2004 Feb; 72(2):194-6. PubMed ID: 14695659
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of immunology effects between live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine].
Wang X; Meng Z; Li R
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):422-4. PubMed ID: 11798797
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis A vaccination of Argentinean infants: comparison of two vaccination schedules.
López EL; Contrini MM; Xifró MC; Cattaneo MA; Zambrano B; Dumas R; Rouyrre N; Weber F
Vaccine; 2007 Jan; 25(1):102-8. PubMed ID: 16914234
[TBL] [Abstract][Full Text] [Related]
13. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E
J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of hepatitis A vaccine in children with celiac disease.
Sari S; Dalgic B; Basturk B; Gonen S; Soylemezoglu O
J Pediatr Gastroenterol Nutr; 2011 Nov; 53(5):532-5. PubMed ID: 21587080
[TBL] [Abstract][Full Text] [Related]
15. [Studies on vaccination schedule of inactivated hepatitis A vaccine].
Hu Y; Tan S; Jin W
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):618-20. PubMed ID: 11798830
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial.
Mayorga Pérez O; Herzog C; Zellmeyer M; Loáisiga A; Frösner G; Egger M
J Infect Dis; 2003 Sep; 188(5):671-7. PubMed ID: 12934183
[TBL] [Abstract][Full Text] [Related]
17. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
Barkai G; Belmaker I; Givon-Lavi N; Dagan R
Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
[TBL] [Abstract][Full Text] [Related]
18. [A comparative study on safety and immunogenicity of an inactivated hepatitis A vaccine in HBsAg carriers and healthy children].
Chen J; Ren Y; Wu W; Ma S; Li S; Wang J; Kang W; Han L; Gao S; Zhang Y; Liu C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):380-1. PubMed ID: 12665912
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
D'Acremont V; Herzog C; Genton B
J Travel Med; 2006; 13(2):78-83. PubMed ID: 16553593
[TBL] [Abstract][Full Text] [Related]
20. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A].
Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M
Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
